ID

22008

Description

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT00313950

Link

https://clinicaltrials.gov/show/NCT00313950

Keywords

  1. 5/14/17 5/14/17 -
Uploaded on

May 14, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Measles NCT00313950

Eligibility Measles NCT00313950

  1. StudyEvent: Eligibility
    1. Eligibility Measles NCT00313950
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 12-13 months on the day of inclusion
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
born at full term of pregnancy (>37 weeks) with a birth weight ≥ 2.5 kg
Description

pregnancy duration, birth weight

Data type

boolean

Alias
UMLS CUI [1]
C0460089
UMLS CUI [2]
C0005612
informed consent form signed by the parent(s) or other legal representative
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
able to attend all scheduled visits and to comply with all trial procedures
Description

trial procedures

Data type

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C2700391
subjects having received only one or no injection of vaccine against measles
Description

measles vaccine

Data type

boolean

Alias
UMLS CUI [1]
C0025010
subjects anti-hav seronegative according to the results obtained at the screening visit*
Description

hav antibodies

Data type

boolean

Alias
UMLS CUI [1]
C0062524
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
participation in another clinical trial in the 4 weeks preceding the (first) trial vaccination
Description

clinical trial participation

Data type

boolean

Alias
UMLS CUI [1]
C2348568
planned participation in another clinical trial during the present trial period
Description

clinical trial participation

Data type

boolean

Alias
UMLS CUI [1]
C2348568
congenital or acquired immunodeficiency, immunosuppressive therapy such as long-term systemic corticosteroids therapy
Description

immunodeficiency, immunosuppression

Data type

boolean

Alias
UMLS CUI [1]
C0021051
UMLS CUI [2]
C0021079
systemic hypersensitivity to any of the vaccines components or history of a life-threatening reaction to the trial vaccines or a vaccine containing the same substances
Description

vaccine hypersensitivity

Data type

boolean

Alias
UMLS CUI [1,1]
C0042210
UMLS CUI [1,2]
C0020517
chronic illness at a stage that could interfere with trial conduct or completion
Description

chronic disease

Data type

boolean

Alias
UMLS CUI [1]
C0008679
blood or blood-derived products received in the past 3 months
Description

blood products

Data type

boolean

Alias
UMLS CUI [1]
C0456388
any vaccination in the 4 weeks preceding the first trial vaccination
Description

vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0042196
vaccination planned in the 4 weeks following any trial vaccination
Description

vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0042196
history of hepatitis a, mumps, measles and/or rubella infection (confirmed either clinically, serologically or microbiologically)
Description

hepatitis a, mumps, measles, rubella infection

Data type

boolean

Alias
UMLS CUI [1]
C0019159
UMLS CUI [2]
C0026780
UMLS CUI [3]
C0025007
UMLS CUI [4]
C0035920
previous vaccination against hepatitis a with the trial vaccine or another vaccine
Description

hepatitis a vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0419735
previous vaccination against mumps, measles and rubella with a mumps, measles and rubella trivalent combined vaccine
Description

mumps measles rubella trivalent combined vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0199810
thrombocytopenia or a bleeding disorder contraindicating intramuscular vaccination
Description

thrombocytopenia, bleeding disorder

Data type

boolean

Alias
UMLS CUI [1]
C0040034
UMLS CUI [2]
C0005779
history of seizures
Description

seizures

Data type

boolean

Alias
UMLS CUI [1]
C0036572
febrile illness (axillary temperature ≥37.4°c]) on the day of inclusion
Description

febrile illness

Data type

boolean

Alias
UMLS CUI [1]
C0743841

Similar models

Eligibility Measles NCT00313950

  1. StudyEvent: Eligibility
    1. Eligibility Measles NCT00313950
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
aged 12-13 months on the day of inclusion
boolean
C0001779 (UMLS CUI [1])
pregnancy duration, birth weight
Item
born at full term of pregnancy (>37 weeks) with a birth weight ≥ 2.5 kg
boolean
C0460089 (UMLS CUI [1])
C0005612 (UMLS CUI [2])
informed consent
Item
informed consent form signed by the parent(s) or other legal representative
boolean
C0021430 (UMLS CUI [1])
trial procedures
Item
able to attend all scheduled visits and to comply with all trial procedures
boolean
C0008976 (UMLS CUI [1,1])
C2700391 (UMLS CUI [1,2])
measles vaccine
Item
subjects having received only one or no injection of vaccine against measles
boolean
C0025010 (UMLS CUI [1])
hav antibodies
Item
subjects anti-hav seronegative according to the results obtained at the screening visit*
boolean
C0062524 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
clinical trial participation
Item
participation in another clinical trial in the 4 weeks preceding the (first) trial vaccination
boolean
C2348568 (UMLS CUI [1])
clinical trial participation
Item
planned participation in another clinical trial during the present trial period
boolean
C2348568 (UMLS CUI [1])
immunodeficiency, immunosuppression
Item
congenital or acquired immunodeficiency, immunosuppressive therapy such as long-term systemic corticosteroids therapy
boolean
C0021051 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
vaccine hypersensitivity
Item
systemic hypersensitivity to any of the vaccines components or history of a life-threatening reaction to the trial vaccines or a vaccine containing the same substances
boolean
C0042210 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
chronic disease
Item
chronic illness at a stage that could interfere with trial conduct or completion
boolean
C0008679 (UMLS CUI [1])
blood products
Item
blood or blood-derived products received in the past 3 months
boolean
C0456388 (UMLS CUI [1])
vaccination
Item
any vaccination in the 4 weeks preceding the first trial vaccination
boolean
C0042196 (UMLS CUI [1])
vaccination
Item
vaccination planned in the 4 weeks following any trial vaccination
boolean
C0042196 (UMLS CUI [1])
hepatitis a, mumps, measles, rubella infection
Item
history of hepatitis a, mumps, measles and/or rubella infection (confirmed either clinically, serologically or microbiologically)
boolean
C0019159 (UMLS CUI [1])
C0026780 (UMLS CUI [2])
C0025007 (UMLS CUI [3])
C0035920 (UMLS CUI [4])
hepatitis a vaccination
Item
previous vaccination against hepatitis a with the trial vaccine or another vaccine
boolean
C0419735 (UMLS CUI [1])
mumps measles rubella trivalent combined vaccination
Item
previous vaccination against mumps, measles and rubella with a mumps, measles and rubella trivalent combined vaccine
boolean
C0199810 (UMLS CUI [1])
thrombocytopenia, bleeding disorder
Item
thrombocytopenia or a bleeding disorder contraindicating intramuscular vaccination
boolean
C0040034 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
seizures
Item
history of seizures
boolean
C0036572 (UMLS CUI [1])
febrile illness
Item
febrile illness (axillary temperature ≥37.4°c]) on the day of inclusion
boolean
C0743841 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial